An Assessment of the Current Use of Human Interferons in Therapy of Urological Cancers
- 1 November 1989
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 142 (5), 1173-1180
- https://doi.org/10.1016/s0022-5347(17)39022-5
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- INTERFERONS IN CANCER THERAPY: A REAPPRAISALThe Lancet, 1987
- Recombinant Interferon Enhances Monoclonal Antibody-Targeting of Carcinoma Lesions in VivoScience, 1987
- Phase I study of multiple dose intramuscularly administered recombinant gamma interferon.Journal of Clinical Oncology, 1986
- Safety and tolerance of recombinant interferon alfa-2a (roferon®-A) in Cancer PatientsCancer, 1986
- Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosisJournal of Clinical Immunology, 1986
- Clinical toxicity of interferons in cancer patients: a review.Journal of Clinical Oncology, 1986
- Comparison of Intramuscular and Intravenous Recombinant Alpha-2 Interferon in Melanoma and Other CancersAnnals of Internal Medicine, 1985
- InterferonThe Prostate, 1984
- The human interferons—From protein purification and sequence to cloning and expression in bacteria: Before, between, and beyondArchives of Biochemistry and Biophysics, 1983
- Virus interference. I. The interferonProceedings of the Royal Society of London. Series B - Biological Sciences, 1957